Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32330 subjects from the international cannabis consortium

Translational Psychiatry

Volumn 6, Issue 3, 2016, Pages

  Stringer, S ^a,b   Minica C C ^a   Verweij, K J H ^a,c,d   Mbarek, H ^a   Bernard, M ^e   Derringer, J ^f   van Eijk, K R ^g   Isen, J D ^h   Loukola, A ⁱ   Maciejewski, D F ^d   Mihailov, E ^j   van der Most, P J ^k   Sanchez Mora C ^l,m,n   Roos, L ^o   Sherva, R ^p   Walters, R ^q,r,s   Ware, J J ^t   Abdellaoui, A ^a   Bigdeli, T B ^u   Branje, S J T ^v   Brown, S A ^w   Bruinenberg, M ^x   Casas, M ^l,m,n   Esko, T ^j   Garcia Martinez, I ^l,m   Gordon, S D ^y   Harris, J M ^o   Hartman, C A ^k   Henders, A K ^y   Heath, A C ^z   Hickie, I B ^aa   Hickman, M ^t   Hopfer, C J ^ab   Hottenga, J J ^a   Huizink, A C ^d   Irons, D E ^h   Kahn, R S ^g   Korhonen, T ^i,ac,ad   Kranzler, H R ^ae   Krauter, K ^af   van Lier, P A C ^d   Lubke, G H ^a,ag   Madden, P A F ^z   Magi R ^j   McGue, M K ^h   Medland, S E ^y   Meeus, W H J ^v,ah   Miller, M B ^h   Montgomery, G W ^y   Nivard, M G ^a   Nolte, I M ^k   Oldehinkel, A J ^k   Pausova, Z ^e,ai   Qaiser, B ⁱ   Quaye, L ^o   Ramos Quiroga, J A ^l,m,n   Richarte, V ^m   Rose, R J ^aj   Shin, J ^e   Stallings, M C ^af   Stiby, A I ^t   Wall, T L ^w   Wright, M J ^y   Koot, H M ^d   Paus, T ^ai,ak,al   Hewitt, J K ^af   Ribases M ^l,m,n   Kaprio, J ^i,ad   Boks, M P ^g   Snieder, H ^k   Spector, T ^o   Munafo M R ^t   Metspalu, A ^j   Gelernter, J ^am   Boomsma, D I ^a,c   Iacono, W G ^h   Martin, N G ^y   Gillespie, N A ^u,y   Derks, E M ^b   Vink, J M ^a,an   more..

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU University ^*  (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j UNIVERSITY OF TARTU   (Estonia)

^k UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^l UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^m HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁿ CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q MASSACHUSETTS GENERAL HOSPITAL   (United States)

^r BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^s HARVARD MEDICAL SCHOOL   (United States)

^t UNIVERSITY OF BRISTOL   (United Kingdom)

^u VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v UTRECHT UNIVERSITY   (Netherlands)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UNIVERSITY OF GRONINGEN   (Netherlands)

^y QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^z WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa UNIVERSITY OF SYDNEY   (Australia)

^ab UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^ac UNIVERSITY OF EASTERN FINLAND   (Finland)

^ad NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ae UNIVERSITY OF PENNSYLVANIA   (United States)

^af UNIVERSITY OF COLORADO   (United States)

^ag UNIVERSITY OF NOTRE DAME   (United States)

^ah TILBURG UNIVERSITY   (Netherlands)

^ai UNIVERSITY OF TORONTO   (Canada)

^aj INDIANA UNIVERSITY   (United States)

^ak ROTMAN RESEARCH INSTITUTE   (Canada)

^al CHILD MIND INSTITUTE   (United States)

^am YALE UNIVERSITY   (United States)

^an RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CADM2 PROTEIN, HUMAN; CARRIER PROTEIN; CD56 ANTIGEN; CELL ADHESION MOLECULE; KCNT2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NCAM1 PROTEIN, HUMAN; POTASSIUM CHANNEL; SCOC PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CADM2 GENE; CANNABIS ADDICTION; CANNABIS USE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENOME-WIDE ASSOCIATION STUDY; HERITABILITY; HUMAN; KCNT2 GENE; MAJOR CLINICAL STUDY; MALE; NCAM1 GENE; SCOC GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE USE; CANNABIS SMOKING; GENETICS; META ANALYSIS; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD56; CARRIER PROTEINS; CELL ADHESION MOLECULES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MEMBRANE PROTEINS; MIDDLE AGED; POTASSIUM CHANNELS; YOUNG ADULT;

EID: 85011976876     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2016.36     Document Type: Article

References (71)

1. United Nations Office on Drugs and Crime. 2010 World Drug Report, New York, USA, 2010.
2. Hall W, Solowij N. Adverse effects of cannabis. Lancet 1998; 352: 1611–1616.
3. Hall W, Babor TF. Cannabis use and public health: assessing the burden. Addiction 2000; 95: 485–490.
4. Aggarwal SK, Carter GT, Sullivan MD, ZumBrunnen C, Morrill R, Mayer JD. Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. J Opioid Manag 2009; 5: 153–168.
5. Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction 2014; 110: 19–35.
6. Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med 2014; 371: 879.
7. Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP. Cannabis use and mania symptoms: a systematic review and meta-analysis. J Affect Disord 2014; 171c: 39–47.
8. Radhakrishnan R, Wilkinson ST, D'Souza DC. Gone to pot: a review of the association between cannabis and psychosis. Front Psychiatry 2014; 5: 54.
9. French L, Gray C, Leonard G, Perron M, Pike GB, Richer L et al. Early cannabis use, polygenic risk score for schizophrenia and brain maturation in adolescence. JAMA Psychiatry 2015; 72: 1002–1011.
10. Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313: 2456–2473.
11. Cressey D. The cannabis experiment. Nature 2015; 524: 280–283.
12. Verweij KJH, Zietsch BP, Lynskey MT, Medland SE, Neale MC, Martin NG et al. Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction 2010; 105: 417–430.
13. Gillespie NA, Lubke GH, Gardner CO, Neale MC, Kendler KS. Two-part random effects growth modeling to identify risks associated with alcohol and cannabis initiation, initial average use and changes in drug consumption in a sample of adult, male twins. Drug Alcohol Depend 2012; 123: 220–228.
14. Gillespie NA, Neale MC, Kendler KS. Pathways to cannabis abuse: a multi-stage model from cannabis availability, cannabis initiation and progression to abuse. Addiction 2009; 104: 430–438.
15. Agrawal A, Neale MC, Jacobson KC, Prescott CA, Kendler KS. Illicit drug use and abuse/dependence: modeling of two-stage variables using the CCC approach. Addict Behav 2005; 30: 1043–1048.
16. Agrawal A, Morley KI, Hansell NK, Pergadia ML, Montgomery GW, Statham DJ et al. Autosomal linkage analysis for cannabis use behaviors in Australian adults. Drug Alcohol Depend 2008; 98: 185–190.
17. Agrawal A, Pergadia ML, Saccone SF, Lynskey MT, Wang JC, Martin NG et al. An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. Arch Gen Psychiatry 2008; 65: 713–722.
18. Ehlers CL, Gilder DA, Gizer IR, Wilhelmsen KC. Heritability and a genome-wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian community. Addict Biol 2009; 14: 338–348.
19. Ehlers CL, Gizer IR, Vieten C, Wilhelmsen KC. Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco Family Study. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 802–811.
20. Hopfer CJ, Lessem JM, Hartman CA, Stallings MC, Cherny SS, Corley RP et al. A genome-wide scan for loci influencing adolescent cannabis dependence symp-toms: evidence for linkage on chromosomes 3 and 9. Drug Alcohol Depend 2007; 89: 34–41.
21. Verweij KJH, Zietsch BP, Liu JZ, Medland SE, Lynskey MT, Madden PAF et al. No association of candidate genes with cannabis use in a large sample of Australian twin families. Addict Biol 2012; 17: 687–690.
22. Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction 2008; 103: 1678–1686.
23. Lind PA, Macgregor S, Agrawal A, Montgomery GW, Heath AC, Martin NG et al. The role of GABRA2 in alcohol dependence, smoking, and illicit drug use in an Australian population sample. Alcohol Clin Exp Res 2008; 32: 1721–1731.
24. Agrawal A, Lynskey MT. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction 2009; 104: 518–532.
25. Agrawal A, Lynskey MT, Hinrichs A, Grucza R, Saccone SF, Krueger R et al. A genome-wide association study of DSM-IV cannabis dependence. Addict Biol 2011; 16: 514–518.
26. Verweij KJH, Vinkhuyzen AAE, Benyamin B, Lynskey MT, Quaye L, Agrawal A et al. The genetic aetiology of cannabis use initiation: a meta-analysis of genome-wide association studies and a SNP-based heritability estimation. Addict Biol 2013; 18: 846–850.
27. Minică CC, Dolan CV, Hottenga J-J, Pool R, Fedko IO, Mbarek H et al. Heritability, SNP-and gene-based analyses of cannabis use initiation and age at onset. Behav Genet 2015; 45: 503–513, 1-11.
28. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747–753.
29. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012; 13: 537–551.
30. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 2010; 42: 448–U135.
31. Furberg H, Kim Y, Dackor J, Boerwinkle E, Franceschini N, Ardissino D et al. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 2010; 42: 441–U134.
32. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010; 42: 366–368.
33. Kendler KS, Karkowski LM, Corey LA, Prescott CA, Neale MC. Genetic and environmental risk factors in the aetiology of illicit drug initiation and subsequent misuse in women. Br J Psychiatry 1999; 175: 351–356.
34. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE et al. An integrated map of genetic variation from 1092 human genomes. Nature 2012; 491: 56–65.
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
36. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genome-wide association scans. Bioinformatics 2010; 26: 2190–2191.
37. Sham PC, Purcell SM. Statistical power and significance testing in large-scale genetic studies. Nat Rev Genet 2014; 15: 335–346.
38. Li MX, Gui HS, Kwan JS, Sham PC. GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am J Hum Genet 2011; 88: 283–293.
39. Li MX, Kwan JS, Sham PC. HYST: a hybrid set-based test for genome-wide association studies, with application to protein-protein interaction-based association analysis. Am J Hum Genet 2012; 91: 478–488.
40. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289–300.
41. So HC, Li M, Sham PC. Uncovering the total heritability explained by all true susceptibility variants in a genome-wide association study. Genet Epidemiol 2011; 35: 447–456.
42. Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet 2015; 47: 291–295.
43. Bulik-Sullivan BK, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR et al. An atlas of genetic correlations across human diseases and traits. Nat Genet 2015; 47: 1236–1241.
44. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36: 1–48.
45. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 2006; 15: 3498–3507.
46. Rubinek T, Yu R, Hadani M, Barkai G, Nass D, Melmed S et al. The cell adhesion molecules N-cadherin and neural cell adhesion molecule regulate human growth hormone: a novel mechanism for regulating pituitary hormone secretion. J Clin Endocrinol Metab 2003; 88: 3724–3730.
47. Ducci F, Kaakinen M, Pouta A, Hartikainen AL, Veijola J, Isohanni M et al. TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways lead-ing to smoking behavior from adolescence to mid-adulthood. Biol Psychiatry 2011; 69: 650–660.
48. Bidwell LC, McGeary JE, Gray JC, Palmer RH, Knopik VS, MacKillop J. NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence. Psychopharmacology 2015; 232: 1177–1186.
49. Gelernter J, Panhuysen C, Weiss R, Brady K, Poling J, Krauthammer M et al. Genomewide linkage scan for nicotine dependence: identification of a chromo-some 5 risk locus. Biol Psychiatry 2007; 61: 119–126.
50. Laucht M, Becker K, Frank J, Schmidt MH, Esser G, Treutlein J et al. Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. J Am Acad Child Adolesc Psychiatry 2008; 47: 673–681.
51. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PAF et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007; 16: 36–49.
52. Munafo M, Clark T, Johnstone E, Murphy M, Walton R. The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 2004; 6: 583–597.
53. Yang BZ, Kranzler HR, Zhao HY, Gruen JR, Luo XG, Gelernter J. Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case-control and family samples. Hum Mol Genet 2007; 16: 2844–2853.
54. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J. Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcohol Clin Exp Res 2008; 32: 2117–2127.
55. Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand FL et al. ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. JAMA Psychiatry 2013; 70: 325–333.
56. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937–948.
57. Ibrahim-Verbaas CA, Bressler J, Debette S, Schuur M, Smith AV, Bis JC et al. GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Mol Psychiatry 2015; 21: 189–197.
58. Casey JP, Magalhaes T, Conroy JM, Regan R, Shah N, Anney R et al. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet 2012; 131: 565–579.
59. Hayatbakhsh MR, O'Callaghan MJ, Mamun AA, Williams GM, Clavarino A, Najman JM. Cannabis use and obesity and young adults. Am J Drug Alcohol Abuse 2010; 36: 350–356.
60. Kelleher LM, Stough C, Sergejew AA, Rolfe T. The effects of cannabis on information-processing speed. Addict Behav 2004; 29: 1213–1219.
61. De Alwis D, Agrawal A, Reiersen AM, Constantino JN, Henders A, Martin NG et al. ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins. J Stud Alcohol Drugs 2014; 75: 211–221.
62. Mason JM, Arndt KM. Coiled coil domains: stability, specificity, and biological implications. Chembiochem 2004; 5: 170–176.
63. Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H et al. Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry 2014; 76: 66–74.
64. Gelernter J, Sherva R, Koesterer R, Almasy L, Zhao H, Kranzler HR et al. Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol Psychiatry 2014; 19: 717–723.
65. Yang JA, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88: 76–82.
66. Agrawal A, Silberg JL, Lynskey MT, Maes HH, Eaves LJ. Mechanisms underlying the lifetime co-occurrence of tobacco and cannabis use in adolescent and young adult twins. Drug Alcohol Depend 2010; 108: 49–55.
67. Kendler KS, Schmitt E, Aggen SH, Prescott CA. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry 2008; 65: 674–682.
68. Manchia M, Cullis J, Turecki G, Rouleau GA, Uher R, Alda M. The impact of phenotypic and genetic heterogeneity on results of genome wide association studies of complex diseases. PLoS One 2013; 8: e76295.
69. Grant JD, Lynskey MT, Scherrer JF, Agrawal A, Heath AC, Bucholz KK. A cotwin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use. Addict Behav 2010; 35: 35–41.
70. Agrawal A, Lynskey MT, Pergadia ML, Bucholz KK, Heath AC, Martin NG et al. Early cannabis use and DSM-IV nicotine dependence: a twin study. Addiction 2008; 103: 1896–1904.
71. Lynskey MT, Vink JM, Boomsma DI. Early onset cannabis use and progression to other drug use in a sample of Dutch twins. Behav Genet 2006; 36: 195–200.